Type : |
Journal |
Internet-link : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4750 |
|
forskerhold : |
Sydney - National Institute of Complementary Medicine, Western Sydney University |
Forfattere : |
Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J. |
Titel : |
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. |
Nummer : |
Int J Pharm Compound ;24,1:77-82 2020 |
|
cotationvaleur : |
|
fysisk stabilitet : |
|
kemisk stabilitet : |
|
andre metoder : |
|
Kommentarer : |
|
Lister
Metronidazole
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
3000 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
25°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg ® = ? |
|
4°C |
|
90 |
|
|
|
|
|
|
150 mg Metrogyl® |
|
4°C |
|
90 |
|
|
|
|
|